BOGLE INVESTMENT MANAGEMENT L P /DE/ - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2018$2,868,000
-38.9%
272,592
-44.2%
0.22%
-35.1%
Q3 2015$4,692,000
-61.7%
488,819
-42.6%
0.33%
-63.5%
Q2 2015$12,245,000
+160.1%
851,538
+10.3%
0.91%
+191.7%
Q4 2014$4,708,000771,8420.31%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
ClearBridge Investments 14,428,856$55,840,0000.06%
View complete list of IMMUNOGEN INC shareholders